ZA200105690B - Novel treatment. - Google Patents

Novel treatment.

Info

Publication number: ZA200105690B
Authority: ZA; South Africa
Prior art keywords: novel treatment; novel; treatment
Prior art date: 1999-01-12

Application number

ZA200105690A

Other languages

English (en)

Inventor

Atkinson Gillian Frances

Boon Ronald James

Pierre G Vandepapeliere

Wettendorff Martine Ann Cecile

Original Assignee

Smithkline Beecham Biolog

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-01-12

Filing date

2001-07-11

Publication date

2002-09-25

2001-07-11 Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog

2002-09-25 Publication of ZA200105690B publication Critical patent/ZA200105690B/xx

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Virology (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Immunology (AREA)
Microbiology (AREA)
Mycology (AREA)
Endocrinology (AREA)
Biotechnology (AREA)
Oncology (AREA)
Gastroenterology & Hepatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

ZA200105690A 1999-01-12 2001-07-11 Novel treatment. ZA200105690B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB9900630		1999-01-12

Publications (1)

Publication Number	Publication Date
ZA200105690B true ZA200105690B (en)	2002-09-25

Family

ID=10845878

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200105690A ZA200105690B (en)	1999-01-12	2001-07-11	Novel treatment.

Country Status (19)

Country	Link
EP (1)	EP1140163A2 (xx)
JP (1)	JP2002534438A (xx)
KR (1)	KR20010090011A (xx)
CN (1)	CN1391482A (xx)
AR (1)	AR022250A1 (xx)
AU (1)	AU760574B2 (xx)
BR (1)	BR9916893A (xx)
CA (1)	CA2359110A1 (xx)
CO (1)	CO5241355A1 (xx)
CZ (1)	CZ20012544A3 (xx)
HK (1)	HK1041434A1 (xx)
HU (1)	HUP0105070A2 (xx)
IL (1)	IL144186A0 (xx)
NO (1)	NO20013337L (xx)
NZ (1)	NZ512890A (xx)
PL (1)	PL349347A1 (xx)
TR (1)	TR200102024T2 (xx)
WO (1)	WO2000041463A2 (xx)
ZA (1)	ZA200105690B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1999061056A2 (en)	1998-05-22	1999-12-02	Loeb Health Research Institute At The Ottawa Hospital	Methods and products for inducing mucosal immunity
CN1560078B (zh)	1998-07-31	2011-06-22	株式会社国际癌症免疫研究所	基于癌抑制基因wt1的产物的癌抗原
CA2440303C (en)	2001-03-22	2013-03-19	Haruo Sugiyama	Wt1 modified peptide
US8735357B2 (en)	2001-09-28	2014-05-27	International Institute Of Cancer Immunology, Inc.	Method of inducing antigen-specific T cells
JPWO2003028758A1 (ja) *	2001-09-28	2005-01-13	治夫杉山	抗原特異的ｔ細胞の誘導方法
MY131488A (en) *	2002-04-08	2007-08-30	Bristol Myers Squibb Co	Low dose liquid entecavir formulations and use
PT2241325E (pt)	2002-10-29	2012-04-12	Coley Pharm Gmbh	Utilização de oligonucleótidos cpg no tratamento de infecção com vírus da hepatite c
AU2003300919A1 (en)	2002-12-11	2004-06-30	Coley Pharmaceutical Gmbh	5' cpg nucleic acids and methods of use
CN100443117C (zh) *	2003-05-13	2008-12-17	深圳康泰生物制品股份有限公司	一种治疗性乙型肝炎的疫苗制剂、其制备方法及其用途
US8541167B2 (en)	2004-06-03	2013-09-24	Saint Louis University	Methods and compositions for vaccination
AR065504A1 (es) *	2007-02-28	2009-06-10	Ct Ingenieria Genetica Biotech	Terapia combinada para el tratamiento de la hepatitis b cronica. uso.
WO2020134682A1 (zh) *	2018-12-24	2020-07-02	南京远大赛威信生物医药有限公司	用于治疗乙型肝炎的药物制剂及其制备方法和用途
EP4321173A1 (en) *	2021-04-07	2024-02-14	Denka Company Limited	Adjuvant activity enhancer and adjuvant composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2109921T3 (es) *	1989-07-25	1998-02-01	Smithkline Beecham Biolog	Nuevos antigenos y procedimientos para su preparacion.
EP1064025B1 (en) *	1998-03-09	2006-09-13	GlaxoSmithKline Biologicals S.A.	Combined vaccine compositions

1999
- 1999-12-21 PL PL99349347A patent/PL349347A1/xx not_active Application Discontinuation
- 1999-12-21 KR KR1020017008833A patent/KR20010090011A/ko not_active Application Discontinuation
- 1999-12-21 CN CN99816471A patent/CN1391482A/zh active Pending
- 1999-12-21 CZ CZ20012544A patent/CZ20012544A3/cs unknown
- 1999-12-21 AU AU21009/00A patent/AU760574B2/en not_active Ceased
- 1999-12-21 TR TR2001/02024T patent/TR200102024T2/xx unknown
- 1999-12-21 EP EP99965531A patent/EP1140163A2/en not_active Withdrawn
- 1999-12-21 HU HU0105070A patent/HUP0105070A2/hu unknown
- 1999-12-21 IL IL14418699A patent/IL144186A0/xx unknown
- 1999-12-21 JP JP2000593088A patent/JP2002534438A/ja active Pending
- 1999-12-21 WO PCT/EP1999/010295 patent/WO2000041463A2/en not_active Application Discontinuation
- 1999-12-21 CA CA002359110A patent/CA2359110A1/en not_active Abandoned
- 1999-12-21 BR BR9916893-6A patent/BR9916893A/pt not_active IP Right Cessation
- 1999-12-21 NZ NZ512890A patent/NZ512890A/en unknown
2000
- 2000-01-11 AR ARP000100107A patent/AR022250A1/es not_active Application Discontinuation
- 2000-01-12 CO CO00001261A patent/CO5241355A1/es not_active Application Discontinuation
2001
- 2001-07-05 NO NO20013337A patent/NO20013337L/no not_active Application Discontinuation
- 2001-07-11 ZA ZA200105690A patent/ZA200105690B/xx unknown
2002
- 2002-02-19 HK HK02101211.9A patent/HK1041434A1/zh unknown

Also Published As

Publication number	Publication date
KR20010090011A (ko)	2001-10-17
TR200102024T2 (tr)	2001-12-21
EP1140163A2 (en)	2001-10-10
CZ20012544A3 (cs)	2002-01-16
AR022250A1 (es)	2002-09-04
JP2002534438A (ja)	2002-10-15
HK1041434A1 (zh)	2002-07-12
NO20013337L (no)	2001-08-17
WO2000041463A3 (en)	2000-11-09
PL349347A1 (en)	2002-07-15
IL144186A0 (en)	2002-05-23
NO20013337D0 (no)	2001-07-05
WO2000041463A2 (en)	2000-07-20
AU2100900A (en)	2000-08-01
CA2359110A1 (en)	2000-07-20
CO5241355A1 (es)	2003-01-31
NZ512890A (en)	2003-09-26
BR9916893A (pt)	2001-11-20
HUP0105070A2 (hu)	2002-04-29
AU760574B2 (en)	2003-05-15
CN1391482A (zh)	2003-01-15

Publication	Publication Date	Title
MXPA01013362A (es)	2003-09-04	Anticuerpos de humano, anti-alfavbeta3 recombinantes, °cidos nucleicos que codifican a los mismos y metodos de uso.
ZA200200477B (en)	2003-06-25	2-pyrazolin-5-ones.
EG24361A (en)	2009-03-04	4-pyrimiding1-n-acy1.l.phenlalanines
ZA200202537B (en)	2003-09-23	Pour-on-formulations.
HK1051199A1 (en)	2003-07-25	New phenylpiperazines.
HK1053470A1 (en)	2003-10-24	4-Pyridinyln-acyl-l-phenylalanines.
HK1029502A1 (en)	2001-04-06	Slider-pull-assembling unit.
EG25829A (en)	2012-09-02	Novel treatment
HK1029817A1 (en)	2001-04-12	Belt.
GB9925136D0 (en)	1999-12-22	Novel treatment
ZA200105690B (en)	2002-09-25	Novel treatment.
ZA200108489B (en)	2003-03-26	Tampon.
AU5547000A (en)	2001-01-02	Novel treatment
MXPA00007601A (es)	2003-07-28	Cronometro.
AU4556800A (en)	2000-11-10	Novel treatment
MXPA02000261A (es)	2003-08-20	Aminoindanos novedosos.
ZA200204156B (en)	2003-07-30	Water treatment.
GB0029720D0 (en)	2001-01-17	I.S machine7544232001
ZA200110046B (en)	2003-03-06	Therapeutic agents.
ZA200109120B (en)	2003-11-13	Use of Arylalkanoylpyridazines.
ZA200204581B (en)	2003-08-27	Nitro-sulfobenzamides.
GB0029125D0 (en)	2001-01-10	Novel treatment
HK1031254A1 (en)	2001-06-08	Tachogragh.
GB9916655D0 (en)	1999-09-15	Novel treatment
GB9920787D0 (en)	1999-11-03	Novel treatment